Although people generally talk about “cancer”, it is clear that the disease occurs in a bewildering variety of forms. Even single groups of cancers, such as those of the white blood cells, may show widely differing properties. How do the various cancers arise and what factors determine their progression

International study that included St. Jude Children’s Research Hospital reports some young acute lymphoblastic leukemia patients who fail induction therapy can achieve high cure rates without bone marrow transplantation. An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction therapy.

Log in to manage your products and services from The New York Times and the International Herald Tribune.

Published on March 29, 2012 at 6:46 PM By Dr Ananya Mandal, MD According to a federal appeals court it would not reconsider a ruling that allows bone marrow donors to be paid for their donations like blood donors. In December, the 9th U.S. Circuit Court of Appeals overturned a decades-old government practice that made such compensation a crime.

By: Mahita Gajanan / Staff Writer Posted on 30. Mar, 2012 in News For one Pitt alumnus, a simple cheek swab was enough to begin a process that would eventually help save a childs life. In 2010, Jenna Tamburro, then a sophomore, registered at Pitts first annual bone marrow drive sponsored by the Nursing Student Association through DKMS, a bone marrow donation center.

Arkansas State University-Newport will host a Bone Marrow Donor Drive on campus Thursday, March 29 from 10am until 7pm and Saturday, March 31 from 9am until 1pm in the Student/Community Center, Merchants & Planters Insurance and Investments room. A bone marrow transplant is a lifesaving treatment for people with leukemia, lymphoma and many other diseases

Volunteers will stake out locations all over Athens today from the downtown Waffle House at 2 a.m., to Athens City Hall at 4 p.m.

Displaying rare unanimity on an issue, the full U.S. 9th Circuit Court of Appeals on Tuesday rejected a request by the federal government thatit reconsidera rulingthat most bone marrow donors can be compensated for providing life-saving marrow stem cells from their blood. A three-judge panel of the appeals court ruled on Dec.

ScienceDaily (Mar. 26, 2012) A research network led by a Mayo Clinic physician found that stem cells derived from heart failure patients’ own bone marrow and injected into their hearts improved the function of the left ventricle, the heart’s pumping chamber. Researchers also found that certain types of the stem cells were associated with the largest improvement and warrant further study

A research network led by a Mayo Clinic physician found that stem cells derived from heart failure patients’ own bone marrow and injected into their hearts improved the function of the left ventricle, the heart’s pumping chamber. Researchers also found that certain types of the stem cells were associated with the largest improvement and warrant further study

Public release date: 24-Mar-2012 [ | E-mail | Share ] Contact: Traci Klein newsbureau@mayo.edu 507-284-5005 Mayo Clinic CHICAGO — A research network led by a Mayo Clinic physician found that stem cells derived from heart failure patients’ own bone marrow and injected into their hearts improved the function of the left ventricle, the heart’s pumping chamber. Researchers also found that certain types of the stem cells were associated with the largest improvement and warrant further study

HOUSTON – Doctors from the Texas Heart Institute at St. Luke’s Episcopal Hospital have found that patients with heart failure may be able to repair the damaged areas of the heart with stem cells from the patient’s own bone marrow. Doctors presented the findings at the American College of Cardiologys 61st Annual Scientific Session Saturday.

By Prue Salasky 3:48 p.m. EDT, March 23, 2012 UVA recently performed the first two stem cell transplants in Virginia, using non-embryonic stem cells from umbilical cord blood.

Public release date: 24-Mar-2012 [ | E-mail | Share ] Contact: Jade Waddy Jade.Waddy@uth.tmc.edu 713-500-3030 JAMA and Archives Journals Use of a patient’s bone marrow cells for treating chronic ischemic heart failure did not result in improvement on most measures of heart function, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology’s annual scientific sessions

ScienceDaily (Mar. 24, 2012) Use of a patient’s bone marrow cells for treating chronic ischemic heart failure did not result in improvement on most measures of heart function, according to a study appearing in JAMA.

By Uduak Grace Thomas Users of ChimerMarker, a short tandem repeat chimerism analysis software solution marketed by SoftGenetics, are reporting a significant reduction in the time required to analyze STRs in blood samples of patients who have undergone bone marrow transplants. The tool automates the process of assessing the chimerism ratio the proportion of donor cells relative to the host patients own cells in post-transplant cases based on the presence of STRs that are unique to both the patient and the donor, Don Kristt, head of molecular pathology at the Rabin Medical Center in Israel, explained to BioInform this week. According to SoftGenetics, the software can be used to monitor chimerism levels in allogeneic and autologous stem cell transplants or hematopoietic stem cell transplants; bone marrow transplants; and cord and peripheral blood stem cell transplant samples.

What used to be medical trash is now treating cancer. The University of Virginia’s Medical Center is the first place in Virginia to take advantage of stem cells from umbilical cords and they are pleased with the results.

Editor’s Choice Academic Journal Main Category: Lymphoma / Leukemia / Myeloma Article Date: 23 Mar 2012 – 8:00 PDT email to a friend printer friendly opinions Current Article Ratings: The drug blocks these cells from binding to bone marrow by driving them into the bloodstream, where they are more susceptible to chemotherapy. Geoffrey L. Uy, M.D., co-first author on the study and assistant professor of medicine, said: 52 individuals with acute myeloid leukemia (AML) whose AML was resistant to the standard chemotherapy regimen or who had relapsed, were enrolled to participate in the combined Phase I and II clinical trial.

Debbi Margosian Chapmans family hopes you will and is offering $10,000 to the person who is a bone marrow match for her to treat her leukemia.

ScienceDaily (Mar. 21, 2012) Powerful new cells created by Cardiff scientists from cheek lining tissue could offer the answer to disorders of the immune system